KR20170133714A - Chinese medicine ointment - Google Patents

Chinese medicine ointment Download PDF

Info

Publication number
KR20170133714A
KR20170133714A KR1020160064851A KR20160064851A KR20170133714A KR 20170133714 A KR20170133714 A KR 20170133714A KR 1020160064851 A KR1020160064851 A KR 1020160064851A KR 20160064851 A KR20160064851 A KR 20160064851A KR 20170133714 A KR20170133714 A KR 20170133714A
Authority
KR
South Korea
Prior art keywords
weight
parts
ointment
treatment
prostatitis
Prior art date
Application number
KR1020160064851A
Other languages
Korean (ko)
Inventor
리밍 인
Original Assignee
리밍 인
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리밍 인 filed Critical 리밍 인
Priority to KR1020160064851A priority Critical patent/KR20170133714A/en
Publication of KR20170133714A publication Critical patent/KR20170133714A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288Taraxacum (dandelion)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/744Gardenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8964Anemarrhena
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

Disclosed is a medicinal herb-based ointment for treating prostatitis, containing the following ingredients: 10-25 parts by weight of Radix Bupleuri, 10-25 parts by weight of Rhizoma Anemarrhenae, 3-11 parts by weight of Fructus Gardeniae, 3-11 parts by weight of Lycium barbarum, 3-11 parts by weight of Radix Paeoniae Rubra, and 3-11 parts by weight of Flos Chrysanthemi.

Description

한방 연고{Chinese medicine ointment} Chinese medicine ointment

본 발명은 한방약 분야에 속하는 전립선염 치료용 한방 연고에 관한 것이다.The present invention relates to a herbal ointment for treating prostatitis belonging to the field of oriental medicine.

전립선염은 흔한 성인 남성 생식기관 질환으로서, 주로 젊은 층과 노인층이 대상이 되며, 빈번한 배뇨, 긴급 배뇨, 배뇨통(odynuria), 배뇨장애(paruria), 끊임없는 요의(endless micturition desire), 요도 가려움증, 배뇨후 잔뇨, 전립선 유체의 과류(overflow), 요도구에서 점사(viscin thread) 및 액체의 존재, 항문 위치에서 통증 및 펜던트(pendant) 팽배 느낌 (상이한 수준으로), 고환 부기 통증, 은밀한 부위 부기 통증, 허리 아픔, 그리고 성기능장애(이를 테면 발기부전, 조기사정 등)의 주요 임상적 증상을 나타낸다. 전립선염은, 신장의 기운을 북돋우게 하고, 양(YANG)을 강화시키고, 혈액 순환을 촉진시켜 울혈을 제거하고, 그리고 이뇨를 촉진시키고, 탁도를 소개시킴으로써, 열과 독성 물질을 제거하는 효과를 발휘할 수 있는 통상적인 치료 방법에 의해 통상적으로 치료된다. 경구 투여되거나, 또는 외용으로 이용되는 한방약, 양약 및 한방약과 양약의 혼합 제제가 포함하는 전립선염을 치료하는 다양한 선행기술이 있다. 상기 약물에 의해 혈액 순환을 촉진시켜 울혈을 제거하고, 심장을 깨끗하게 하고, 이뇨를 촉진시키고, 염증을 감소시키고, 통증을 완화시키고, 그리고 통증배뇨를 치료하고, 이뇨를 촉진시키는 효과를 얻을 수 있다. 그러나, 현재 전립선염을 치료하기 위한 특이적인 약물은 없고, 선행기술에서 약물의 치료 효과는 만족스럽지 못하다. Prostatitis is a common adult male reproductive organs disease that is predominantly in the young and elderly population and is characterized by frequent urination, urgent urination, odynuria, paruria, endless micturition desire, , Urinary retention after voiding, overflow of the prostate fluid, presence of viscin thread and liquid in the urethral area, pain and pendant sensation in the anus position (to different levels), testicular annular pain, , Back pain, and sexual dysfunction (such as erectile dysfunction, premature ejaculation, etc.). Prostatitis has the effect of removing heat and toxic substances by boosting the energy of the kidneys, strengthening the quantity (YANG), promoting blood circulation, removing congestion, promoting diuretic and introducing turbidity Which is usually treated by conventional treatment methods. There are various prior arts for treating prostatitis, including oral administration, herbal medicine used for external use, herbal medicine, and a mixed preparation of herbal medicine and herbal medicine. The drug can be used to promote blood circulation to remove congestion, to clean the heart, to promote diuretic, to reduce inflammation, to relieve pain, to treat pain urination, and to promote diuretic . However, currently, there is no specific drug for the treatment of prostatitis, and the therapeutic effect of the drug in the prior art is unsatisfactory.

따라서, 전립선염 치료에 더 나은 치료 효과를 가진 한방 조제물이 여전히 필요하다. 현재까지, 본 발명의 신규성을 부정할 수 있는 자료는 없다. 전립선염 치료에 더 나은 효과를 가지는 한방 조제물을 얻기 위하여, 본 발명의 발명자는 임상 적용 및 반복된 검증을 통하여 수년간 정교한 연구를 실행함으로써 방대한 임상 관찰 자료를 수집하였고, 이로 인하여 본 발명이 완성되었다.Therefore, there is still a need for herbal preparations that have a better therapeutic effect in the treatment of prostatitis. Until now, there is no data that can deny the novelty of the present invention. In order to obtain herbal preparations having a better effect on the treatment of prostatitis, the inventors of the present invention collected vast clinical observation data by conducting elaborate research for many years through clinical application and repeated verification, thereby completing the present invention .

본 발명의 목적은 즉효를 가지는 전립선염 치료용 한방 연고를 제공하는 것이다.It is an object of the present invention to provide an ointment for treatment of prostatitis having an immediate effect.

본 발명은 다음과 같이 실현된다: 상기 전립선염 치료용 한방 연고는 다음의 원료를 포함한다: 시호(Radix Bupleuri), 지모(Rhizoma Anemarrhenae), 치자(Fructus Gardeniae), 구기자(Lycium barbarum), 작약(Radix Paeoniae Rubra), 및 국화꽃(Flos Chrysanthemi); 더 나은 치료효과를 얻기 위하여, 상기 원료들은 민들레(Dandelion) 및 울금(Radix Curcumae)과 배합될 수 있으며; 그리고 더 나은 치료효과를 얻기 위하여, 복령(Poria cocos)이 첨가될 수 있다.The present invention is realized as follows: The herbal ointment for treating prostatitis includes the following ingredients: Radix Bupleuri, Rhizoma Anemarrhenae, Fructus Gardeniae, Lycium barbarum, peony Radix Paeoniae Rubra), and Chrysanthemi (Flos Chrysanthemi); In order to obtain a better therapeutic effect, the raw materials can be combined with Dandelion and Radix Curcumae; In order to obtain better therapeutic effect, Poria cocos can be added.

다음의 범위내 원료들이 포함된 본 발명의 한방 연고는 우수한 치료효과를 갖는다: The herbal ointment of the present invention containing raw materials within the following ranges has excellent therapeutic effects:

시호 10-25 중량부, 지모 10-25 중량부, 치자 3-11 중량부, 구기자 3-11 중량부, 작약 3-11 중량부, 및 국화꽃 3-11 중량부.10-25 parts by weight of Seishi, 10-25 parts by weight of gum, 3-11 parts by weight of gardenia, 3-11 parts by weight of ginger, 3-11 parts by weight of peony root, and 3-11 parts by weight of chrysanthemum flower.

바람직하게는, 시호 15 중량부, 지모 15 중량부, 치자 5 중량부, 구기자 5 중량부, 작약 5 중량부, 및 국화꽃 5 중량부.Preferably, 15 parts by weight of Seicho, 15 parts by weight of gum, 5 parts by weight of gardenia, 5 parts by weight of ginger, 5 parts by weight of peony root, and 5 parts by weight of chrysanthemum flower.

또한, 본 발명의 한방 연고는 다음의 범위내 원료들을 포함할 수 있다: 시호 10-25 중량부, 지모 10-25 중량부, 치자 3-11 중량부, 구기자 3-11 중량부, 작약 3-11 중량부, 및 국화꽃 3-11 중량부, 민들레 3-15 중량부 및 울금 3-11 중량부.The ointment of the present invention may also contain ingredients in the following ranges: 10-25 parts by weight of Seal, 10-25 parts by weight of gum, 3-11 parts by weight of gardenia, 3-11 parts by weight of ginger, 3- 11 to 3 parts by weight of chrysanthemum flowers, 3 to 15 parts by weight of dandelion, and 3 to 11 parts by weight of chestnut.

바람직하게는, 시호 15 중량부, 지모 15 중량부, 치자 5 중량부, 구기자 5 중량부, 작약 5 중량부, 국화꽃 5 중량부, 민들레 7.5 중량부 및 울금 5 중량부.Preferably, 15 parts by weight of Seishi, 15 parts by weight of ginger, 5 parts by weight of gardenia, 5 parts by weight of ginger, 5 parts by weight of ginger, 5 parts by weight of chrysanthemum flower, 7.5 parts by weight of dandelion and 5 parts by weight of ginger.

또한, 본 발명의 한방 연고는 다음의 범위내 원료들을 포함할 수 있다: 시호 10-25 중량부, 지모 10-25 중량부, 치자 3-11 중량부, 구기자 3-11 중량부, 작약 3-11 중량부, 및 국화꽃 3-11 중량부, 민들레 3-15 중량부 및 울금 3-11 중량부, 복령 5-20 중량부.The ointment of the present invention may also contain ingredients in the following ranges: 10-25 parts by weight of Seal, 10-25 parts by weight of gum, 3-11 parts by weight of gardenia, 3-11 parts by weight of ginger, 3- And 3 to 11 parts by weight of chrysanthemum flowers, 3 to 15 parts by weight of dandelion and 3 to 11 parts by weight of cormorant, and 5 to 20 parts by weight of gypsum.

바람직하게는, 시호 15 중량부, 지모 15 중량부, 치자 5 중량부, 구기자 5 중량부, 작약 5 중량부, 국화꽃 5 중량부, 민들레 7.5 중량부, 울금 5 중량부, 및 복령 10 중량부.Preferably, 15 parts by weight of Seishi, 15 parts by weight of ginger, 5 parts by weight of gardenia, 5 parts by weight of ginger, 5 parts by weight of peony powder, 5 parts by weight of chrysanthemum flower, 7.5 parts by weight of dandelion, 5 parts by weight of ginger, .

원칙적으로, 본 발명의 한방 연고의 제법은 문헌[참조: Technical requirements for study of new traditional Chinese medicine technology (ZHONG YAO XIN YAO ZHI BEI GONG YI YAN JIU DE JI SHU YAO QIU)]에 기록된 방법에 따르며, 이 방법은 다음을 포함한다: 현재 제법 신기술을 이용하여 주원료들을 연고에 사용되는 물질로 만들고, 햇빛 아래서 이들을 건조시키고, 이들을 200 메쉬(mesh) 초과로 분쇄시키고, 연고로 만들기 위하여 의료용 바셀린과 같은 일부 첨가물을 첨가하여, 항문 직장의 전립선 위치에서 직접적으로 작용할 수 있다. 본 발명은 외용 좌약과 같은 다른 투약형을 더 가질 수도 있다.In principle, the preparation of the herbal composition of the present invention is carried out according to the method described in Technical requirements for study of new traditional Chinese medicine technology (ZHONG YAO XIN YAO ZHI BEI GONG YI YAN JIU DE JI SHU YAO QIU) This method includes: making use of current recipe technologies to make APIs the materials used for ointment, drying them under the sun, crushing them to over 200 mesh, and adding some additives such as medical vaseline to make ointments May act directly at the prostate location of the anus rectum. The present invention may also have other dosage forms such as topical suppositories.

본 발명의 한방 연고의 투여량은 5일간의 치료 과정으로 일일 2회, 1회 약 2-4g (질환의 심각성에 따라 의사의 지시에 의해)이다. 1-2차례 치료 과정 후 회복 치료 효과를 실질적으로 얻을 수 있으며, 1-2회 치료 과정의 추가 강화요법 후, 임상적으로 회복 효과를 얻을 수 있다. 임상 검증에서 본 발명의 한방 연고는 재발율이 낮은 것으로 나타났다.The dose of the herbal ointment of the present invention is about 2-4 g (once a doctor's instruction depending on the severity of the disease) twice a day for 5 days of treatment. After 1 to 2 times of treatment, it is possible to obtain a therapeutic effect substantially, and clinically recovering effect can be obtained after further strengthening therapy of 1-2 times of treatment. In clinical validation, the recurrence rate of the present invention was low.

본 발명의 한방 연고는 항문의 전립선 위치에서 직접적으로 작용하고, 약물이 전립선 막으로 신속하게 침투하고, 혈액 순환을 촉진시켜 울혈을 제거하고, 심장을 깨끗하게 하고, 이뇨를 촉진시키고, 염증을 감소시키고, 통증을 완화시키고, 통증배뇨를 치료하고, 이뇨를 촉진시키고, 이로 인하여 세균을 근절시키고, 염증을 제거하는 효과를 신속하게 얻는다. The herbal ointment of the present invention acts directly at the prostate position of the anus, rapidly penetrates into the prostate gland, promotes blood circulation, removes congestion, cleanses the heart, promotes diuresis, reduces inflammation , To relieve pain, to treat pain urination, to promote diuretic, thereby eliminating germs and eliminating inflammation quickly.

본 발명은 임상적 관찰 테스트와 실시예에 의해 더 상세하게 설명될 것이다.The present invention will be described in more detail by clinical observation tests and examples.

실시예Example 1 본1 copy 발명의 한방 연고의 제조  Manufacture of an ointment of invention

다음에 따라 원료의 무게를 잰다: 시호 15 중량부, 지모 15 중량부, 치자 5 중량부, 구기자 5 중량부, 작약 5 중량부, 및 국화꽃 5 중량부.Weigh the raw materials as follows: 15 parts by weight of Seiho, 15 parts by weight of gum, 5 parts by weight of gardenia, 5 parts by weight of ginger, 5 parts by weight of peony root, and 5 parts by weight of chrysanthemum flower.

실시예Example 2 2

민들레 7.5 중량부 및 울금 5 중량부는 실시예 1에 근거하여 첨가된다.7.5 parts by weight of dandelion and 5 parts by weight of corn were added based on Example 1.

실시예Example 3 3

복령 10 중량부은 실시예 2에 근거하여 첨가된다. 10 parts by weight of Bokryo was added based on Example 2.

원칙적으로, 본 발명의 한방 연고의 제법은 문헌[참조: Technical requirements for study of new traditional Chinese medicine technology (ZHONG YAO XIN YAO ZHI BEI GONG YI YAN JIU DE JI SHU YAO QIU)]에 기록된 방법에 따르며, 이 방법은 다음을 포함한다: 현재 제법 신기술을 이용하여 주원료들을 연고에 사용되는 물질로 만들고, 햇빛 아래서 이들을 건조시키고, 이들을 200 메쉬(mesh)초과로 분쇄시키고, 의료용 바셀린을 첨가하여 연고로 만든다. In principle, the preparation of the herbal composition of the present invention is carried out according to the method described in Technical requirements for study of new traditional Chinese medicine technology (ZHONG YAO XIN YAO ZHI BEI GONG YI YAN JIU DE JI SHU YAO QIU) These methods include: making the APIs into materials for ointment using current recipe technology, drying them under sunlight, pulverizing them to over 200 mesh, and adding medical vaseline to ointment.

실시예Example 4 본 발명의 한방 좌약의 제조 4 Preparation of herbal suppositories of the present invention

다음에 따라 원료의 무게를 잰다: 시호 15 중량부, 지모 15 중량부, 치자 5 중량부, 구기자 5 중량부, 작약 5 중량부, 및 국화꽃 5 중량부.Weigh the raw materials as follows: 15 parts by weight of Seiho, 15 parts by weight of gum, 5 parts by weight of gardenia, 5 parts by weight of ginger, 5 parts by weight of peony root, and 5 parts by weight of chrysanthemum flower.

실시예Example 5 5

민들레 7.5 중량부 및 울금 5 중량부는 실시예 4에 근거하여 첨가된다.7.5 parts by weight of dandelion and 5 parts by weight of corn were added based on Example 4.

실시예Example 6 6

복령 10 중량부는 실시예 5에 근거하여 첨가된다. 10 parts by weight of Bamboo is added based on Example 5.

원칙적으로, 본 발명의 한방 좌약의 제법은 문헌[참고: Technical requirements for study of new traditional Chinese medicine technology (ZHONG YAO XIN YAO ZHI BEI GONG YI YAN JIU DE JI SHU YAO QIU)]에 기록된 방법에 따르며, 이 방법은 다음을 포함한다: 현재 제법 신기술을 이용하여 주원료들을 연고에 사용되는 물질로 만들고, 햇빛 아래서 이들을 건조시키고, 이들을 200 메쉬(mesh)초과로 분쇄시키고, 일부 첨가제를 첨가하여 가용성 한방 좌약으로 만든다. In principle, the preparation of the herbal suppositories of the present invention is carried out according to the method described in the technical requirements for study of new traditional Chinese medicine technology (ZHONG YAO XIN YAO ZHI BEI GONG YI YAN JIU DE JI SHU YAO QIU) These methods include: making the APIs into materials for ointment using current recipe techniques, drying them under sunlight, pulverizing them to over 200 mesh, adding some additives to the soluble one-part suppositories I make it.

테스트 1 임상 치료 효과 관찰 자료Test 1 Clinical treatment effect observation data

1. 임상 일반 자료1. Clinical data

281명의 환자들이 선별되었으며, 이때 30세 미만인 환자 36명, 30-35세 연령대의 환자 55명, 35-40세 연령대의 환자 68명, 40-45세 연령대의 환자 80명, 그리고 45세 초과의 환자 42명이며; 최고령 환자는 70세이며, 최연소 환자는 21세이고; 미혼이 49명이며, 232명의 환자는 기혼이며; 6개월 또는 그 이내의 병력을 가진 환자는 43명이며, 6개월 내지 12개월의 병력을 가진 환자는 144명이며, 12-18개월의 병력을 가진 환자는 56명이며, 18개월 초과의 병력을 가진 환자는 38명이다.A total of 281 patients were selected, including 36 patients aged less than 30 years, 55 patients aged 30-35 years, 68 patients aged 35-40 years, 80 patients aged 40-45 years, 42 patients; The oldest patient is 70 years old, the youngest patient is 21 years old; 49 were single, 232 were married; There were 43 patients with a history of 6 months or less, 144 patients with a history of 6 to 12 months, 56 patients with a history of 12-18 months, There are 38 patients.

2. 진단 기준2. Diagnostic Criteria

(1) 주요 임상적 증상은 다음과 같다: 빈번한 배뇨, 긴급 배뇨, 배뇨통, 배뇨장애, 끊임없는 요의, 요도 가려움증, 배뇨후 잔뇨, 전립선 유체의 과류, 요도구에서 점사 및 액체의 존재, 항문 위치에서 통증 및 펜던트 팽배 느낌 (상이한 수준으로), 고환 부기 통증, 은밀한 부위 부기 통증, 허리 아픔, 그리고 성기능장애(이를 테면 발기부전, 조기사정 등).(1) Major clinical symptoms include: frequent urination, urgent urination, voiding cessation, urinary incontinence, irregular urination, urethral itching, urinary retention, urination of the prostate fluid, presence of drops and fluid in the urethra, Pain and pendant impingement (at different levels), testicular annular pain, secret site swelling, back pain, and sexual dysfunction (such as erectile dysfunction, premature ejaculation, etc.).

(2)전립선 유체 검사: 신체의 렉틴 수준이 감소되며, 모든 높은 전력장에서 백혈구 수는 10 초과거나 또는 농구(pyocyte) 수준은 “+”이상이다. (2) Prostate fluid test: the body's lectin level is reduced, and at all high power fields the leukocyte count is above 10 or the "pyocyte" level is above "+".

(3) 세균 검사: Meares 방법에 따라 세균 배양물, 카운팅, 및 약물 감수성 테스트를 실행함으로써 110명의 환자를 검사하는데, 이때 72명의 환자는 병원성 세균 공격으로 고통을 받고 있으며; 38명의 환자는 병원성 세균 공격을 받지 않았다.(3) Bacteria testing: 110 patients are examined by performing bacterial culture, counting, and drug susceptibility testing according to the Meares method, in which 72 patients are suffering from pathogenic bacterial attacks; 38 patients were not exposed to pathogenic bacteria.

3. 치료 방법: 전립선염의 병인론 및 발병기전에 따라, 본 발명의 한방에 포함된 원료는 햇볕에서 건조되며, 200 메쉬 초과로 분쇄시키고, 일부 첨가제(가령, 의료용 바셀린)를 첨가하여 연고로 만들고, 불순물을 제거한 후, 본 발명의 한방 연고는 (질병의 심각성에 따라 의사의 지시에 의해) 5일간의 치료 일정으로 이틀에 한번씩 1회 2-4 g의 투여량으로 항문의 전립선 위치에 직접 바른다. 1-2차례 치료 과정 후 회복 치료 효과를 실질적으로 얻을 수 있으며, 1-2회 치료 과정의 추가 강화요법 후, 임상적으로 치료 효과를 얻을 수 있다. 3. Methods of treatment: According to the etiology and pathogenesis of prostatitis, the raw materials contained in one of the present invention are dried in the sun, pulverized to a size exceeding 200 mesh, made into ointment by adding some additives (for example, medical vaseline) The ointment of the present invention is applied directly to the anus of the anal prostate at a dose of 2-4 g once every two days with a 5-day treatment schedule (according to the physician's instruction according to the severity of the disease). After 1 to 2 times of treatment, it is possible to obtain the therapeutic effect substantially. Therapeutic effect can be obtained clinically after the additional treatment of 1-2 times of the treatment.

4. 치료 효과의 평가 기준4. Criteria for evaluation of therapeutic effect

회복: 임상적 증상이 사라지고, 그리고 모든 높은 전력장에서 백혈구 수는 10 미만이 되고, 신체의 렉틴 수준이 정상으로 회복된다.Recovery: Clinical symptoms disappear, and in all high power fields the leukocyte count is less than 10, and the body's lectin levels return to normal.

유의적인 효과: 임상적 증상이 실질적으로 또는 유의적으로 완화되며, 전립선 유체 정기 검사에서 대략 정상으로 나타나며, 유의적인 전립선 접촉통증은 없다.Significant effects: Clinical symptoms are substantially or significantly relieved, appear approximately normal in the prostate fluid examination, and there is no significant prostate contact pain.

개선: 자각증상이 사라지거나 또는 유의적으로 경감되고, 압통은 없고, 전립선 유체 정기 검사에서 백혈구 수치는 상당히 감소되며, 신체의 렉틴 수준은 증가되거나, 또는 실질적으로 정상인 것으로 나타난다.Improvement: The subjective symptoms disappear or are significantly relieved, there is no tenderness, the leukocyte count is significantly reduced in the prostate fluid examination, and the body's lectin level is increased or substantially normal.

효과없음: 2회 이상의 치료 과정 후, 증상이 유의적으로 경감되지 않고, 그리고 관련된 지수에서 유의적인 변화가 없다. No effect: After two or more treatment courses, the symptoms are not significantly relieved and there is no significant change in the relevant index.

5. 치료 결과5. Treatment Results

통상적인 치료법으로 1-2회 치료 과정 후, 임상 증상은 신속하게 경감될 수 있다. 회복 환자 수는 140명 (49.8%)이며, 유의적인 효과를 나타내는 환자 수는 51명 (18.1%)이며, 개선을 보인 환자 수는 34명 (12.1%)이며, 효과가 없는 환자 수는 56명(20%)이고; 따라서 전체 효과율은 80%이다.After 1-2 courses of treatment with conventional therapy, clinical symptoms can be relieved quickly. The number of recovery patients was 140 (49.8%), and the number of patients showing significant effect was 51.1 (18.1%), the improvement was 34 (12.1%), (20%); Therefore, the overall effectiveness rate is 80%.

추가 강화요법으로 1-2회 치료 과정 후, 임상 증상은 신속하게 사라지고, 체질은 정상으로 복귀된다. 회복 환자 수는 168명 (59.8%)이며, 유의적인 효과를 나타내는 환자 수는 62 명(22.1%)이며, 개선을 보인 환자 수는 39명 (13.9%)이며, 효과가 없는 환자 수는 12명 (4.2%)이고; 따라서 전체 효과율은 95.8%이다.After 1-2 courses of treatment with additional intensive therapy, clinical symptoms disappear quickly, and the constitution returns to normal. The number of patients recovered was 168 (59.8%), and the number of patients showing a significant effect was 62 (22.1%). The number of patients showing improvement was 39 (13.9%), (4.2%); Therefore, the overall effectiveness rate is 95.8%.

Claims (5)

다음을 포함하는, 전립선염 치료용 한방 연고: 시호(Radix Bupleuri) 10-25 중량부, 지모(Rhizoma Anemarrhenae) 10-25 중량부, 치자(Fructus Gardeniae) 3-11 중량부, 구기자(Lycium barbarum) 3-11 중량부, 작약(Radix Paeoniae Rubra) 3-11 중량부, 및 국화꽃(Flos Chrysanthemi) 3-11 중량부.10 to 25 parts by weight of Radix Bupleuri, 10 to 25 parts by weight of Rhizoma Anemarrhenae, 3 to 11 parts by weight of Fructus Gardeniae, Lycium barbarum, 3-11 parts by weight of Radix Paeoniae Rubra, 3-11 parts by weight of Radix Paeoniae Rubra and 3-11 parts by weight of Flos Chrysanthemi. 제1항에 있어서, 다음을 포함하는, 전립선염 치료용 한방 연고: 시호 15 중량부, 지모 15 중량부, 치자 5 중량부, 구기자 5 중량부, 작약 5 중량부, 및 국화꽃 5 중량부.The ointment preparation for treating prostatitis according to claim 1, which comprises 15 parts by weight of Seicho, 15 parts by weight of gum, 5 parts by weight of gardenia, 5 parts by weight of ginger, 5 parts by weight of peony powder, and 5 parts by weight of chrysanthemum flower. 제1항에 있어서, 다음을 더 포함하는, 전립선염 치료용 한방 연고: 민들레(Dandelion) 3-15 중량부 및 울금(Radix Curcumae) 3-11 중량부.The ointment according to claim 1 further comprising: 3-15 parts by weight of Dandelion and 3-11 parts by weight of Radix Curcumae for the treatment of prostatitis. 제3항에 있어서, 다음을 포함하는, 전립선염 치료용 한방 연고: 시호 15 중량부, 지모 15 중량부, 치자 5 중량부, 구기자 5 중량부, 작약 5 중량부, 및 국화꽃 5 중량부, 민들레 7.5 중량부 및 울금 5 중량부.The ointment according to claim 3, which comprises 15 parts by weight of Seishi, 15 parts by weight of gum, 5 parts by weight of gardenia, 5 parts by weight of ginger, 5 parts by weight of peony powder, 5 parts by weight of chrysanthemum flower, 7.5 parts by weight of dandelion and 5 parts by weight of corn. 제3항에 있어서, 다음을 더 포함하는, 전립선염 치료용 한방 연고: 복령(Poria cocos) 5-20 중량부.The ointment according to claim 3, further comprising: 5-20 parts by weight of Poria cocos for the treatment of prostatitis.
KR1020160064851A 2016-05-26 2016-05-26 Chinese medicine ointment KR20170133714A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160064851A KR20170133714A (en) 2016-05-26 2016-05-26 Chinese medicine ointment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160064851A KR20170133714A (en) 2016-05-26 2016-05-26 Chinese medicine ointment

Publications (1)

Publication Number Publication Date
KR20170133714A true KR20170133714A (en) 2017-12-06

Family

ID=60922529

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160064851A KR20170133714A (en) 2016-05-26 2016-05-26 Chinese medicine ointment

Country Status (1)

Country Link
KR (1) KR20170133714A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108042744A (en) * 2018-01-02 2018-05-18 威海惠高生物科技有限公司 A kind of Chinese medicine composition and preparation method for being used to treat prostatic disorders
CN109620890A (en) * 2019-02-25 2019-04-16 黄章贤 Chinese medicine composition, liquid medicine and the preparation method of promoting circulation of blood diuresis defaecation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108042744A (en) * 2018-01-02 2018-05-18 威海惠高生物科技有限公司 A kind of Chinese medicine composition and preparation method for being used to treat prostatic disorders
CN109620890A (en) * 2019-02-25 2019-04-16 黄章贤 Chinese medicine composition, liquid medicine and the preparation method of promoting circulation of blood diuresis defaecation

Similar Documents

Publication Publication Date Title
CN104940727A (en) Paste for treating rhinitis and preparation method thereof
CN103301408B (en) Traditional Chinese medicine extract and massage cream prepared from extract
CN104398640A (en) Traditional Chinese medicinal composition for treating prostatitis, and preparation method thereof
CN103494891A (en) Traditional Chinese medicine composition for treating dermatoses and preparation method thereof
CN103142879B (en) Traditional Chinese medicine for treating rubella
KR20170133714A (en) Chinese medicine ointment
CN102872300B (en) Traditional Chinese medicine for treating non-gonococcal urethritis
CN102793870B (en) Chinese herbal medicine for treating renal calculi
CN104173920A (en) Medicine for treating lymphoma
CN103536855A (en) Traditional Chinese medicinal prescription for treating kidney stones and preparation method thereof
CN104398949B (en) One kind treats prostatitic traditional Chinese medicine oral liquid
CN103386101B (en) Traditional Chinese medicine preparation for nonspecific cystitis treatment and preparation method thereof
CN105998974A (en) Traditional Chinese medicine composition and gels for treating gynecologic inflammation and preparation method thereof
CN101390964A (en) Cataplasm of traditional Chinese medicine for treating hyperosteogeny
CN110151971A (en) It is a kind of for treating the gel and its production method of male prostatitis
CN108042601A (en) A kind of drug for treating acute and chronic soft tissue injury and preparation method thereof
CN104127827A (en) Traditional Chinese medicine for treating biliary calculi
CN103656063A (en) Medicine for treating chronic prostatitis
CN103751533B (en) A kind of for postoperative traditional Chinese medicine for external application of varicocele and preparation method thereof
CN106421645B (en) Medicine for treating hyperplasia of mammary glands and ovarian cyst
CN104840897A (en) Traditional Chinese medicine for treating prosopalgia
CN104971308A (en) Traditional Chinese medicine composition for treating chronic prostatitis
CN105561213A (en) External application traditional Chinese medicine used for acute gouty arthritis
KR20170133036A (en) Chinese medicine ointment for treating prostatitis
CN104306734A (en) Plaster preparation for external use for treating diabetic gangrene and preparation method thereof

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E601 Decision to refuse application